IGC Pharma extends loan agreement with O-Bank; facility fees cut to $84,000 from $120,000

IGC Pharma, Inc.

Extension effective July 8, 2024, extends term of existing Master Loan and Security Agreement under same terms.
Facility fees reduced to $84,000 from $120,000; no other material changes to the agreement.
The loan agreement was previously disclosed in July 2023 8-K; this amendment solely extends the term.
No new borrowing or change in principal amount; obligation remains under existing credit facility.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.